PMID: 7686336

Meschede D, Eigel A, Horst J, Nieschlag E
Compound heterozygosity for the delta F508 and F508C cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a patient with congenital bilateral aplasia of the vas deferens.
Am J Hum Genet. 1993 Jul;53(1):292-3., [PubMed]
Sentences
No. Mutations Sentence Comment
7 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:7:116
status: NEW
view ABCC7 p.Phe508Cys details
(1992) describe a peculiar pattern of heteroduplex formation in a case of compound heterozygosity for the AF508 and F508C mutations in the CFTR gene (cystic fibrosis transmembrane conductance regulator gene). Login to comment
16 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:16:198
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:16:215
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:16:227
status: NEW
view ABCC7 p.Phe508Cys details
Apart from a Table I CFTR Gene Haplotypes in the Patient and His Parents CFTR GENE HAPLOTYPE' MUTATION OR Father of Mother of POLYMORPHISM Patient Patient Patient AF508 ........ AF508/+ AF508/+ +/+ F508C ........ +/F508C +/+ +/F508C M470C ....... +/M470V +/+ +/M470V a A plus sign (+) denotes presence of the wild-type allele. Login to comment
19 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:19:58
status: NEW
view ABCC7 p.Phe508Cys details
Direct sequencing showed heterozygosity for the AF508 and F508C mutations and the amino acid polymorphism M470V (Kerem et al. 1990). Login to comment
23 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:23:38
status: NEW
view ABCC7 p.Phe508Cys details
In the mother, heterozygosity for the F508C mutation and the M470V polymorphism was detected. Login to comment
24 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:24:31
status: NEW
view ABCC7 p.Phe508Cys details
In the patient and his mother, F508C and M470V were present on the same chromosome (cis configuration), as can be deduced from the segregation pattern (table 1). Login to comment
25 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:25:38
status: NEW
view ABCC7 p.Phe508Cys details
Compound heterozygosity for AF508 and F508C has been reported in clinically normal individuals (Kobayashi et al. 1990; Macek et al. 1992), in patients with typical CF symptoms (Kerem et al. 1990), and now, for the first time, in a case of CBAVD. Login to comment
26 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:26:98
status: NEW
view ABCC7 p.Phe508Cys details
The basis for this wide clinical variability is unclear, as is the functional significance of the F508C mutation. Login to comment
28 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:28:141
status: NEW
view ABCC7 p.Phe508Cys details
It cannot be excluded, however, that this mutation contributes to the clinical phenotype of CBAVD if it is inherited together with AF508 and F508C. Login to comment
29 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:29:160
status: NEW
view ABCC7 p.Phe508Cys details
To further clarify this issue, we are currently screening a larger number of patients with congenital anomalies of the Wolffian-duct derivatives, for M470V and F508C mutations. Login to comment
35 ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 7686336:35:152
status: NEW
view ABCC7 p.Phe508Cys details
Am J Hum Genet 47:611-615 Macek M Jr, Ladanyi L, Burger J, Reis A (1992) Missense variations in the cystic fibrosis gene: heteroduplex formation in the F508C mutation. Login to comment